CN116903686A - Whitening compound, preparation method and whitening cosmetic - Google Patents
Whitening compound, preparation method and whitening cosmetic Download PDFInfo
- Publication number
- CN116903686A CN116903686A CN202310892935.4A CN202310892935A CN116903686A CN 116903686 A CN116903686 A CN 116903686A CN 202310892935 A CN202310892935 A CN 202310892935A CN 116903686 A CN116903686 A CN 116903686A
- Authority
- CN
- China
- Prior art keywords
- parts
- whitening
- compound
- arbutin
- hydroquinone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 63
- 239000002537 cosmetic Substances 0.000 title claims abstract description 28
- 150000001875 compounds Chemical class 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 12
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 7
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 229940083957 1,2-butanediol Drugs 0.000 claims abstract description 6
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 108010022355 Fibroins Proteins 0.000 claims abstract description 6
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 6
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 6
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960001631 carbomer Drugs 0.000 claims abstract description 6
- 235000011187 glycerol Nutrition 0.000 claims abstract description 6
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 6
- 239000011718 vitamin C Substances 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000230 xanthan gum Substances 0.000 claims abstract description 6
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 6
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 6
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 6
- 241001122767 Theaceae Species 0.000 claims abstract 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 30
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 26
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 24
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 18
- QWXYZCJEXYQNEI-OSZHWHEXSA-N intermediate I Chemical compound COC(=O)[C@@]1(C=O)[C@H]2CC=[N+](C\C2=C\C)CCc2c1[nH]c1ccccc21 QWXYZCJEXYQNEI-OSZHWHEXSA-N 0.000 claims description 16
- 229960000271 arbutin Drugs 0.000 claims description 13
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000004440 column chromatography Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 239000002585 base Substances 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 3
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 235000011181 potassium carbonates Nutrition 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 235000011118 potassium hydroxide Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- 229940086066 potassium hydrogencarbonate Drugs 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 230000004888 barrier function Effects 0.000 abstract description 3
- 230000001681 protective effect Effects 0.000 abstract description 3
- 230000003020 moisturizing effect Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 239000002131 composite material Substances 0.000 abstract 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 14
- 239000000284 extract Substances 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 102000003425 Tyrosinase Human genes 0.000 description 8
- 108060008724 Tyrosinase Proteins 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 240000000249 Morus alba Species 0.000 description 3
- 235000008708 Morus alba Nutrition 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 2
- 235000003880 Calendula Nutrition 0.000 description 2
- 240000001432 Calendula officinalis Species 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 240000002439 Sorghum halepense Species 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- LBTVHXHERHESKG-UHFFFAOYSA-N tetrahydrocurcumin Chemical compound C1=C(O)C(OC)=CC(CCC(=O)CC(=O)CCC=2C=C(OC)C(O)=CC=2)=C1 LBTVHXHERHESKG-UHFFFAOYSA-N 0.000 description 2
- URJOWNUVTORLNY-UHFFFAOYSA-N (5-hexadecanoyloxy-4-oxopyran-2-yl) hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC1=CC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=CO1 URJOWNUVTORLNY-UHFFFAOYSA-N 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 244000042430 Rhodiola rosea Species 0.000 description 1
- 235000003713 Rhodiola rosea Nutrition 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention provides a whitening compound, a preparation method and a whitening cosmetic, and belongs to the technical field of cosmetics. The composite material is prepared from the following raw materials in parts by weight: 5-7 parts of whitening compound, 1-2 parts of carbomer, 4-5 parts of glycerin, 2-4 parts of 1, 2-butanediol, 1-2 parts of nicotinamide, 0.01-0.03 part of EDTA disodium, 0.2-0.4 part of xanthan gum, 0.5-1 part of vitamin C, 1-2 parts of tea polyphenol, 1-2 parts of silk fibroin and 50-60 parts of water. The whitening cosmetic prepared by the invention has good whitening effect, is easy to absorb, is safe and has no side effect, and can form a protective barrier on the surface of skin, thereby having good whitening and moisturizing effects.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to a whitening compound, a preparation method and a whitening cosmetic.
Background
The pursuit of a beautiful appearance is the nature of everyone, and the condition and appearance of the skin are important components thereof, and healthy and fair skin is pursued by people. For this reason, the demand for whitening cosmetics has been the leading end of various cosmetic demands.
Skin tissue is the first protective barrier of a person and can be broadly divided into epidermis, dermis and subcutaneous tissue. The color of the skin is mainly determined by the amount, size and distribution of melanin contained in skin cells.
The problem with skin lightening is mainly dependent on the ability of melanocytes to synthesize melanin. Between human epidermis basal lamina cells, there are distributed melanocytes, which contain tyrosinase, which is a polyphenol enzyme belonging to the class of oxidoreductases, which are then subjected to a series of metabolic processes to finally produce melanin. The more melanin is produced, the darker the skin; on the contrary, the more fair the skin is. Tyrosinase has unique double catalytic functions, is a key enzyme for melanin synthesis in organisms, and has close relation with human aging. Its abnormal overexpression can lead to pigmentation disorders in humans. Tyrosinase inhibitors can be used for treating pigmentation dermatoses such as freckle, chloasma and senile plaque. Therefore, the arbutin, vitamin C derivatives, kojic acid and derivatives thereof, green tea extracts, licorice extracts and other traditional Chinese medicine extracts in the whitening cosmetics popular in the market at present are all tyrosinase inhibitors, and mainly inhibit melanin synthesis by inhibiting the activity of tyrosinase, thereby playing a role in whitening.
In the patent CN201010214873.4, a whitening composition is disclosed, which contains mulberry bark extract, chamomile extract, rhodiola rosea extract, grape seed extract, licorice extract, mulberry extract, arbutin, kojic dipalmitate, nicotinamide, tetrahydrocurcumin, humectant and preservative, and the effective whitening component in the invention can inhibit the activity of tyrosinase, block melanin transport, inhibit melanin formation, and can be used in whitening cosmetics, and is safe and effective.
The invention discloses a plant extract composition with a whitening function and application thereof in a whitening cosmetic in the patent CN201310210916.5, and the plant extract composition is prepared by compounding a white mulberry root-bark extract, a licorice extract, a peony extract, a kapok extract, an angelica extract and a cortex moutan extract. The plant composition can be used in a whitening formula, and has the functions of inhibiting tyrosinase activity, scavenging free radicals and whitening skin.
In a whitening cosmetic and a preparation method thereof, patent CN201210511695.0 discloses a whitening cosmetic, which is prepared from the following raw materials in percentage by weight: 50 to 70 weight percent of cucumber seed oil, 15 to 25 weight percent of johnsongrass oil and 15 to 25 weight percent of calendula oil, and the preparation method comprises the following steps: 50 to 70 weight percent of cucumber seed oil, 15 to 25 weight percent of johnsongrass oil and 15 to 25 weight percent of calendula oil are mixed at the temperature of 20 to 25 ℃ and stirred uniformly to obtain the product; the whitening cosmetic is prepared from natural vegetable oil, is green and safe, and has no irritation to skin.
Disclosure of Invention
The invention aims to provide a whitening compound, a preparation method and a whitening cosmetic, which have good whitening effect, are easy to absorb, are safe and have no side effect, and can form a protective barrier on the surface of skin, so that good whitening and moisturizing effects are achieved.
The technical scheme of the invention is realized as follows:
the invention provides a whitening compound, which has a structure shown in a formula I:
the invention further provides a preparation method of the whitening compound, which comprises the following steps:
s1, reacting arbutin with thionyl chloride to prepare an intermediate I, wherein the structure is as follows:
s2, reacting the intermediate I with hydroquinone to obtain a product.
As a further improvement of the invention, the mol ratio of arbutin to thionyl chloride in the step S1 is 1:1-1.05.
As a further development of the invention, the molar ratio of intermediate I to hydroquinone in step S2 is 2-2.1:1.
As a further improvement of the present invention, a base is also added in step S2.
As a further improvement of the present invention, the base is at least one selected from NaOH, KOH, sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate.
As a further improvement of the invention, the method specifically comprises the following steps:
s1, dissolving 1 molar equivalent of arbutin and 1-1.05 molar equivalent of thionyl chloride in dichloromethane, and reacting for 20-30min at room temperature to obtain an intermediate I;
s2, dissolving 2-2.1 mol equivalent of intermediate I and 1mol equivalent of hydroquinone in dichloromethane, adding 3-5 mol equivalent of alkali, heating and refluxing for 2-3h, and separating by column chromatography to obtain the product.
The invention further provides a whitening cosmetic containing the whitening compound.
As a further improvement of the invention, the invention is prepared from the following raw materials in parts by weight: 5-7 parts of whitening compound, 1-2 parts of carbomer, 4-5 parts of glycerin, 2-4 parts of 1, 2-butanediol, 1-2 parts of nicotinamide, 0.01-0.03 part of EDTA disodium, 0.2-0.4 part of xanthan gum, 0.5-1 part of vitamin C, 1-2 parts of tea polyphenol, 1-2 parts of silk fibroin and 50-60 parts of water.
The invention has the following beneficial effects: the whitening compound contains the structure of arbutin and hydroquinone, has good whitening effect, can hydrolyze to generate hydroquinone and glucose, and can deactivate enzyme and prevent skin melanin from generating by coagulating amino acid in tyrosinase.
Drawings
In order to more clearly illustrate the embodiments of the invention or the technical solutions of the prior art, the drawings which are used in the description of the embodiments or the prior art will be briefly described, it being obvious that the drawings in the description below are only some embodiments of the invention, and that other drawings can be obtained according to these drawings without inventive faculty for a person skilled in the art.
Fig. 1 is a synthetic route pattern of the whitening compound.
Detailed Description
The following description of the technical solutions in the embodiments of the present invention will be clear and complete, and it is obvious that the described embodiments are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Preparation example 1
As shown in fig. 1, the preparation method of the whitening compound specifically comprises the following steps:
s1, dissolving 0.1mol of arbutin and 0.1mol of thionyl chloride in 200mL of dichloromethane, and reacting for 20min at room temperature to obtain an intermediate I;
s2, dissolving 0.2mol of intermediate I and 0.1mol of hydroquinone in 200mL of dichloromethane, adding 0.3mol of NaOH, heating and refluxing for 2h, and separating by column chromatography to obtain the product with the total yield of 84.2%.
Preparation example 2
As shown in fig. 1, the preparation method of the whitening compound specifically comprises the following steps:
s1, dissolving 0.1mol of arbutin and 0.105mol of thionyl chloride in 200mL of dichloromethane, and reacting for 30min at room temperature to obtain an intermediate I;
s2, dissolving 0.21mol of intermediate I and 0.1mol of hydroquinone in 200mL of dichloromethane, adding 0.5mol of KOH, heating and refluxing for reaction for 3h, and separating by column chromatography to obtain the product with the total yield of 85.4%.
Preparation example 3
As shown in fig. 1, the preparation method of the whitening compound specifically comprises the following steps:
s1, dissolving 0.1mol of arbutin and 0.102mol of thionyl chloride in 200mL of dichloromethane, and reacting at room temperature for 25min to obtain an intermediate I;
s2, dissolving 0.205mol of intermediate I and 0.1mol of hydroquinone in 200mL of dichloromethane, adding 0.4mol of alkali, heating and refluxing for 2.5h, and separating by column chromatography to obtain the product with the total yield of 87.2%.
Example 1
A whitening cosmetic is prepared from the following raw materials in parts by weight: 5 parts of whitening compound, 1 part of carbomer, 4 parts of glycerin, 2 parts of 1, 2-butanediol, 1 part of nicotinamide, 0.01 part of EDTA disodium, 0.2 part of xanthan gum, 0.5 part of vitamin C, 1 part of tea polyphenol, 1 part of silk fibroin and 50 parts of water.
Example 2
A whitening cosmetic is prepared from the following raw materials in parts by weight: 7 parts of whitening compound, 2 parts of carbomer, 5 parts of glycerin, 4 parts of 1, 2-butanediol, 2 parts of nicotinamide, 0.03 part of EDTA disodium, 0.4 part of xanthan gum, 1 part of vitamin C, 2 parts of tea polyphenol, 2 parts of silk fibroin and 60 parts of water.
Example 3
A whitening cosmetic is prepared from the following raw materials in parts by weight: 6 parts of whitening compound, 1.5 parts of carbomer, 4.5 parts of glycerin, 3 parts of 1, 2-butanediol, 1.5 parts of nicotinamide, 0.02 part of EDTA disodium, 0.3 part of xanthan gum, 0.7 part of vitamin C, 1.5 parts of tea polyphenol, 1.5 parts of silk fibroin and 55 parts of water.
Comparative example 1
The difference compared to example 3 is that the whitening compound is replaced by an equivalent amount of hydroquinone.
Comparative example 2
The difference compared to example 3 is that the whitening compound is replaced by an equal amount of arbutin.
Test example 1 antioxidant efficacy test
Experimental group: the whitening cosmetics prepared in examples 1 to 3;
comparison group: the whitening cosmetics prepared in comparative examples 1 to 2;
positive comparative example: reference VC.
0.02604g DPPH (96% by weight) is accurately weighed, dissolved and fixed to 100mL by ethanol with the volume concentration of 95%, and the DPPH concentration is 0.25 g.L -1 And storing for standby. At the time of experiment, 12ml0.25 g.L -1 The DPPH solution of (2) was fixed to 100mL with 95% ethanol, and the DPPH concentration was 0.03 g.L -1 . Baseline was scanned using 95% ethanol as reference solution. 0.03 g.L was measured -1 The DPPH solution of (C) has a maximum absorption wavelength of 518nm at 400-600 nm.
Determination of absorbance of the blank control: 5mL of a DPPH solution of 0.03 g.L-1 was taken in a 10mL EP tube, and 0.1mL of a 95% strength by volume ethanol solution was added thereto and mixed. The absorbance at 518nm was measured and designated A 0 。
Measuring the absorbance of the liquid to be measured: 5mL of 0.03 g.L -1 To the EP tube, 0.1mL of the solution to be measured was added, and the mixture was mixed well. The absorbance at 518nm was measured and designated A i 。
Data processing, namely calculating the clearance E, E=1-A of the obtained data according to the following formula i /A 0 ×100%
The results of the radical scavenging rate obtained by the measurement are shown in Table 1:
TABLE 1
Group of | Clearance (%) |
Positive control | 91.2 |
Example 1 | 94.5 |
Example 2 | 95.1 |
Example 3 | 95.5 |
Comparative example 1 | 83.5 |
Comparative example 2 | 85.2 |
As can be seen from the above table, the whitening cosmetics prepared in examples 1 to 3 of the present invention have good antioxidant effect.
Test example 2 whitening effect test
Volunteers 100 ages (24-55 years), randomly divided into 5 groups, 20 persons each, and tested the whitening cosmetics prepared in examples 1-3 and comparative examples 1-2, respectively. The using method comprises the following steps: 2-4mL of whitening cosmetics are applied at approximately the same time every night for 28 days, and then the results are collected and the test data are summarized in Table 2.
TABLE 2 whitening effect table
Group of | Has obvious effect | In general | Invalidation of | Obvious efficiency (%) | Effective rate (%) |
Example 1 | 17 | 2 | 1 | 85 | 95 |
Example 2 | 16 | 4 | 0 | 80 | 95 |
Example 3 | 18 | 2 | 0 | 90 | 100 |
Comparative example 1 | 6 | 4 | 10 | 30 | 50 |
Comparative example 2 | 9 | 3 | 8 | 45 | 60 |
As can be seen from the above table, the whitening cosmetics prepared in examples 1 to 3 of the present invention have good whitening effect.
The foregoing description of the preferred embodiments of the invention is not intended to be limiting, but rather is intended to cover all modifications, equivalents, alternatives, and improvements that fall within the spirit and scope of the invention.
Claims (9)
1. A whitening compound characterized by having a structure as shown in formula I:
2. a method for preparing the whitening compound as set forth in claim 1, comprising the steps of:
s1, reacting arbutin with thionyl chloride to prepare an intermediate I, wherein the structure is as follows:
s2, reacting the intermediate I with hydroquinone to obtain a product.
3. The method according to claim 2, wherein the molar ratio of arbutin to thionyl chloride in step S1 is 1:1-1.05.
4. The process according to claim 2, wherein the molar ratio of intermediate I to hydroquinone in step S2 is 2-2.1:1.
5. The method according to claim 2, wherein a base is further added in step S2.
6. The method according to claim 5, wherein the base is at least one selected from the group consisting of NaOH, KOH, sodium carbonate, potassium carbonate, sodium hydrogencarbonate and potassium hydrogencarbonate.
7. The preparation method according to claim 2, characterized by comprising the following steps:
s1, dissolving 1 molar equivalent of arbutin and 1-1.05 molar equivalent of thionyl chloride in dichloromethane, and reacting for 20-30min at room temperature to obtain an intermediate I;
s2, dissolving 2-2.1 mol equivalent of intermediate I and 1mol equivalent of hydroquinone in dichloromethane, adding 3-5 mol equivalent of alkali, heating and refluxing for 2-3h, and separating by column chromatography to obtain the product.
8. A whitening cosmetic comprising the whitening compound according to claim 1.
9. The whitening cosmetic according to claim 8, which is prepared from the following raw materials in parts by weight: 5-7 parts of whitening compound, 1-2 parts of carbomer, 4-5 parts of glycerin, 2-4 parts of 1, 2-butanediol, 1-2 parts of nicotinamide, 0.01-0.03 part of EDTA disodium, 0.2-0.4 part of xanthan gum, 0.5-1 part of vitamin C, 1-2 parts of tea polyphenol, 1-2 parts of silk fibroin and 50-60 parts of water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310892935.4A CN116903686A (en) | 2023-07-19 | 2023-07-19 | Whitening compound, preparation method and whitening cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310892935.4A CN116903686A (en) | 2023-07-19 | 2023-07-19 | Whitening compound, preparation method and whitening cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116903686A true CN116903686A (en) | 2023-10-20 |
Family
ID=88361163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310892935.4A Withdrawn CN116903686A (en) | 2023-07-19 | 2023-07-19 | Whitening compound, preparation method and whitening cosmetic |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116903686A (en) |
-
2023
- 2023-07-19 CN CN202310892935.4A patent/CN116903686A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112618400A (en) | Composition for improving skin color and whitening cosmetic | |
KR101887956B1 (en) | Composition for skin lightening comprising extract of Ecklonia cava treated by enzyme | |
CN111281840B (en) | Skin brightening and beautifying cream and preparation method thereof | |
CN105434239B (en) | A kind of application of skin lightening compositions containing natural botanical source in cosmetics | |
CN112933011B (en) | Whitening composition and preparation process and application thereof | |
CN110559248B (en) | Skin-care matrix and preparation method and application thereof | |
CN113797110A (en) | Anti-aging composition containing hydroxypropyl tetrahydropyrane triol and thiotaurine and application thereof | |
CN111329783B (en) | Composition for instantly brightening skin color and application thereof | |
CN111012713B (en) | Whitening composition and preparation method and application thereof | |
CN111166707B (en) | Facial anti-aging repairing and nursing composition and preparation method and application thereof | |
CN116509750A (en) | Composite fish collagen mask liquid and preparation method thereof | |
CN116903686A (en) | Whitening compound, preparation method and whitening cosmetic | |
CN106333874A (en) | Oat hydrating moisturizing sleeping facial mask | |
CN115677633A (en) | Whitening compound, whitening essence and preparation method thereof | |
CN113116753B (en) | Rose essential oil face cream and preparation method thereof | |
CN108309821B (en) | Whitening skin-care mask mud and preparation method thereof | |
KR20210144725A (en) | Anti-aging, antioxidant, anti-inflammatory and whitening agents, and cosmetics | |
JPH08113525A (en) | Beautifying and whitening skin preparation for external use | |
CN115006313B (en) | Fullerene-containing whitening and moisturizing gel mask and preparation method thereof | |
KR20150057390A (en) | Compositions containing an mixed components of dehydro-abietic acid and trans-communic acid for anti-aging | |
CN115227620B (en) | Nourishing, moisturizing and skin brightening lotion and preparation method thereof | |
CN114748387B (en) | Whitening and skin-moistening emulsion | |
CN116514884A (en) | Whitening composition, whitening and beautifying cream and preparation method thereof | |
KR20130089559A (en) | Anti-aging composition | |
KR102160306B1 (en) | skin whitening agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20231020 |